Dysphagia in Head and Neck Cancer With Radiation
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Dec 18, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how radiation treatment affects the ability to swallow in patients with head and neck cancer. Swallowing problems are very common in these patients, affecting around 60-75% of them, and can lead to serious issues like malnutrition and a lower quality of life. The researchers want to understand how different doses of radiation impact the muscles used for swallowing and overall nutrition. To do this, they will assess patients before treatment, three months after, and again within a year after treatment.
To be part of this study, participants need to be between 18 and 80 years old and scheduled to receive radiation or chemotherapy alongside radiation. They should be able to take care of themselves independently and must agree to participate by providing written consent. Unfortunately, people who are scheduled for surgery or have certain health conditions that could interfere with the study won't be eligible. Participants can expect to have their swallowing function monitored closely during the study, helping to advance our understanding of these issues in head and neck cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;
- • Aged between 18 and 80 years;
- • Able to perform self-care independently (ECOG ≤ 2);
- • All patients provide written informed consent.
- Exclusion Criteria:
- • Patients scheduled to undergo surgical treatment;
- • Patients with neuromuscular diseases, such as stroke or Parkinson's disease;
- • Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;
- • Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;
- • Patients who do not consent to undergo high-resolution impedance manometry.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported